132 related articles for article (PubMed ID: 38747879)
1. Mortality related to sickle cell disease and COVID-19 in Brazil, 2020.
Santo AH
Rev Assoc Med Bras (1992); 2024; 70(4):e20231466. PubMed ID: 38747879
[TBL] [Abstract][Full Text] [Related]
2. Sickle cell disease related mortality in Brazil, 2000-2018.
Santo AH
Hematol Transfus Cell Ther; 2022; 44(2):177-185. PubMed ID: 33371971
[TBL] [Abstract][Full Text] [Related]
3. COVID-19 and Sickle Cell Disease-Related Deaths Reported in the United States.
Payne AB; Schieve LA; Abe K; Hulihan M; Hooper WC; Hsu LL
Public Health Rep; 2022; 137(2):234-238. PubMed ID: 35060794
[TBL] [Abstract][Full Text] [Related]
4. Trends in dermatomyositis- and polymyositis-related mortality in the state of São Paulo, Brazil, 1985-2007: multiple cause-of-death analysis.
Santo AH; Souza JM; Pinheiro CE; Souza DC; Sato EI
BMC Public Health; 2010 Oct; 10():597. PubMed ID: 20937106
[TBL] [Abstract][Full Text] [Related]
5. Racial and Ethnic Disparities in Excess Deaths During the COVID-19 Pandemic, March to December 2020.
Shiels MS; Haque AT; Haozous EA; Albert PS; Almeida JS; García-Closas M; Nápoles AM; Pérez-Stable EJ; Freedman ND; Berrington de González A
Ann Intern Med; 2021 Dec; 174(12):1693-1699. PubMed ID: 34606321
[TBL] [Abstract][Full Text] [Related]
6. Mortality attributed to sickle cell disease in children and adolescents in Brazil, 2000-2019.
Nascimento MID; Przibilski ALF; Coelho CSG; Leite KFA; Makenze M; Jesus SB
Rev Saude Publica; 2022; 56():65. PubMed ID: 35792777
[TBL] [Abstract][Full Text] [Related]
7. Cardiovascular mortality in Brazil during the COVID-19 pandemic: a comparison between underlying and multiple causes of death.
Brant LCC; Pinheiro PC; Passaglia LG; de Souza MFM; Malta DC; Banerjee A; Ribeiro ALP; Nascimento BR
Public Health; 2023 Nov; 224():131-139. PubMed ID: 37776607
[TBL] [Abstract][Full Text] [Related]
8. Patterns of mortality in sickle cell disease in adults in France and England.
Perronne V; Roberts-Harewood M; Bachir D; Roudot-Thoraval F; Delord JM; Thuret I; Schaeffer A; Davies SC; Galactéros F; Godeau B
Hematol J; 2002; 3(1):56-60. PubMed ID: 11960397
[TBL] [Abstract][Full Text] [Related]
9. [Multiple-causes-of-death related to tuberculosis in the State of São Paulo, Brazil, 1998].
Santo AH; Pinheiro CE; Jordani MS
Rev Saude Publica; 2003 Dec; 37(6):714-21. PubMed ID: 14666300
[TBL] [Abstract][Full Text] [Related]
10. Global, regional, and national age-sex specific mortality for 264 causes of death, 1980-2016: a systematic analysis for the Global Burden of Disease Study 2016.
GBD 2016 Causes of Death Collaborators
Lancet; 2017 Sep; 390(10100):1151-1210. PubMed ID: 28919116
[TBL] [Abstract][Full Text] [Related]
11. Tracking excess of maternal deaths associated with COVID-19 in Brazil: a nationwide analysis.
Guimarães RM; Reis LGC; de Souza Mendes Gomes MA; Magluta C; de Freitas CM; Portela MC
BMC Pregnancy Childbirth; 2023 Jan; 23(1):22. PubMed ID: 36635674
[TBL] [Abstract][Full Text] [Related]
12. Social inequalities in the temporal trend of mortality from sickle cell disease in Brazil, 1996-2019.
Cordovil K; Tassinari W; Oliveira RVC; Hökerberg Y
Cad Saude Publica; 2023; 39(1):e00256421. PubMed ID: 36651378
[TBL] [Abstract][Full Text] [Related]
13. Maternal mortality in Bahrain with special reference to sickle cell disease.
el-Shafei AM; Sandhu AK; Dhaliwal JK
Aust N Z J Obstet Gynaecol; 1988 Feb; 28(1):41-4. PubMed ID: 3214381
[TBL] [Abstract][Full Text] [Related]
14. Mortality in sickle cell disease. Life expectancy and risk factors for early death.
Platt OS; Brambilla DJ; Rosse WF; Milner PF; Castro O; Steinberg MH; Klug PP
N Engl J Med; 1994 Jun; 330(23):1639-44. PubMed ID: 7993409
[TBL] [Abstract][Full Text] [Related]
15. COVID-19 Infection in Sickle Cell Patients in a Developing Country: A Case Series.
Silva-Pinto AC; Santos-Oliveira L; Santos FLS; Kashima Haddad S; De Santis GC; do Tocantins Calado R
Acta Haematol; 2022; 145(1):1-4. PubMed ID: 34537776
[TBL] [Abstract][Full Text] [Related]
16. Assessment of COVID-19 as the Underlying Cause of Death Among Children and Young People Aged 0 to 19 Years in the US.
Flaxman S; Whittaker C; Semenova E; Rashid T; Parks RM; Blenkinsop A; Unwin HJT; Mishra S; Bhatt S; Gurdasani D; Ratmann O
JAMA Netw Open; 2023 Jan; 6(1):e2253590. PubMed ID: 36716029
[TBL] [Abstract][Full Text] [Related]
17. The unequal impact of the pandemic at subnational levels and educational attainment-related inequalities in COVID-19 mortality, Brazil, 2020-2021.
Szwarcwald CL; Almeida WS; Boccolini CS; Soares Filho AM; Malta DC
Public Health; 2024 Jun; 231():39-46. PubMed ID: 38615470
[TBL] [Abstract][Full Text] [Related]
18. Causes of death in sickle cell disease: an autopsy study.
Manci EA; Culberson DE; Yang YM; Gardner TM; Powell R; Haynes J; Shah AK; Mankad VN;
Br J Haematol; 2003 Oct; 123(2):359-65. PubMed ID: 14531921
[TBL] [Abstract][Full Text] [Related]
19. Trends in Sickle Cell Disease-Related Mortality in the United States, 1979 to 2017.
Payne AB; Mehal JM; Chapman C; Haberling DL; Richardson LC; Bean CJ; Hooper WC
Ann Emerg Med; 2020 Sep; 76(3S):S28-S36. PubMed ID: 32928459
[TBL] [Abstract][Full Text] [Related]
20. Estimating the infection-fatality risk of SARS-CoV-2 in New York City during the spring 2020 pandemic wave: a model-based analysis.
Yang W; Kandula S; Huynh M; Greene SK; Van Wye G; Li W; Chan HT; McGibbon E; Yeung A; Olson D; Fine A; Shaman J
Lancet Infect Dis; 2021 Feb; 21(2):203-212. PubMed ID: 33091374
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
